Carnitine and coenzyme Q10 levels in individuals with Prader-Willi syndrome.
Carnitine and coenzyme Q10 levels in individuals with Prader-Willi syndrome.
复制标题
普拉德威利综合征患者的肉碱和辅酶 Q10 水平。
DOI：
10.1002/ajmg.a.33887
复制
发表时间：
2011
期刊：
影响因子：
--
通讯作者：
Driscoll,DanielJ
中科院分区：
文献类型：
--
作者：
Miller,JenniferL;Lynn,ChristyH;Shuster,Jonathan;Driscoll,DanielJ
Carnitine deficiency or coenzyme Q10 (CoQ10) deficiency may present with hypotonia, poor growth, easy fatigability, and apnea. This constellation of findings can also be seen in individuals with Prader–Willi syndrome (PWS). Animal studies indicate that increased fat mass due to obesity negatively correlates with both carnitine and CoQ10 levels in skeletal muscle. Increased body fat and obesity are characteristic of individuals with PWS. Currently, there is no documentation of serum carnitine levels, and only one study investigating plasma CoQ10 levels, in individuals with PWS. Fasting serum carnitine and plasma CoQ10 levels were measured in 40 individuals with molecularly confirmed PWS (ages 1–27 years; 19 F/21 M), 11 individuals with early‐onset morbid obesity of unknown etiology (ages 3–13 years; 5 F/6 M), and 35 control siblings from both groups (ages 1–24 years; 19 F/16 M). There were no significant differences among the three groups in either total carnitine, free carnitine, or CoQ10 levels. However, individuals with PWS had higher serum levels of carnitine esters (P= 0.013) and higher ester‐to‐free carnitine ratios (P= 0.0096) than controls suggesting a possible underlying impairment of peripheral carnitine utilization and mitochondrial energy metabolism in some individuals with PWS. Serum sampling identified no significant differences in total and free carnitine or CoQ10 levels between individuals with PWS, obese individuals, and sibling control groups. Muscle biopsy or measurement in leukocytes or cultured skin fibroblasts could be a better method to identify abnormalities in carnitine and CoQ10 metabolism in individuals with PWS than peripheral blood sampling. © 2011 Wiley‐Liss, Inc.
